Cite
HARVARD Citation
Schmieder, G. et al. (2018). Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study. British journal of dermatology. pp. 54-62. [Online].